🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alyssa Oplt

Cancer Research Center

ORCID: 0000-0002-9597-9252

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6/AXL pathway and inducing homologous recombination deficiency.”.

Effect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6/AXL pathway and inducing homologous recombination deficiency.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6080

N/A

0DataRank · unranked

0 citations

Elena Lomonosova, Michael Toboni, Hollie Noia, Danny Wilke, Alyssa Oplt +9 more

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

Cancers(2021)10.3390/cancers13235877

N/A

0DataRank · unranked

7 citations

Elena Lomonosova, Shaina F. Bruce, Joan Tankou, Mary M. Mullen, Angela M. Schab +12 more

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0704

N/A

0DataRank · unranked

16 citations

Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt +13 more